株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

ラテラルフローアッセイの世界市場予測 2022年:製品・用途・技術・エンドユーザー別分析

Lateral Flow Assay Market by Product (Reader, Kit), Application (Clinical (Pregnancy, Infectious Disease, Lipid, Cardiac Marker), Veterinary, Drug Development, Food Safety), Technique (Competitive, Multiplex, Sandwich), End User: Global Forecast to 2022

発行 MarketsandMarkets 商品コード 354421
出版日 ページ情報 英文 285 Pages
即納可能
価格
本日の銀行送金レート: 1USD=113.80円で換算しております。
Back to Top
ラテラルフローアッセイの世界市場予測 2022年:製品・用途・技術・エンドユーザー別分析 Lateral Flow Assay Market by Product (Reader, Kit), Application (Clinical (Pregnancy, Infectious Disease, Lipid, Cardiac Marker), Veterinary, Drug Development, Food Safety), Technique (Competitive, Multiplex, Sandwich), End User: Global Forecast to 2022
出版日: 2017年08月14日 ページ情報: 英文 285 Pages
概要

世界のラテラルフローアッセイ市場規模は、2017年から2022年にかけて8.2%のCAGR (年間複合成長率) で推移し、2022年までに82億4,000万米ドルへ達すると予測されています。同市場の成長は主に高齢者人口の増加、感染症の高発生率、在宅ラテラルフローアッセイ試験の利用拡大、分散型またはポイントオブケア診断検査への注目の高まり、および臨床診断におけるラテラルフローアッセイ技術用途の増加によって促進されています。

当レポートでは、世界のラテラルフローアッセイ市場について分析し、市場概要、産業動向、セグメント別の市場分析、競合情勢、主要企業などについて、体系的な情報を提供しています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • ラテラルフローアッセイ市場の概要
  • ラテラルフローアッセイ市場:先進国 vs.発展途上国
  • ラテラルフローアッセイ市場:地域概要
  • ラテラルフローアッセイ市場:地域ミックス
  • アジア太平洋のラテラルフローアッセイ市場:用途別

第5章 市場概要

  • イントロダクション
  • 市場ダイナミクス
    • 促進因子
    • 抑制因子
    • 機会
    • 課題
    • 製品別
    • 技術別
    • アプリケーション別
    • エンドユーザー別

第6章 産業考察

  • イントロダクション
  • 産業動向
  • 規制分析
  • バリューチェーン分析
  • サプライチェーン分析

第7章 世界のラテラルフローアッセイ市場:製品別

  • イントロダクション
  • キット & 試薬
  • ラテラルフローリーダー
    • デジタル/モバイルリーダー
    • ベンチトップリーダー

第8章 世界のラテラルフローアッセイ市場:技術別

  • イントロダクション
  • サンドイッチアッセイ (非競合法)
  • 競合アッセイ (競合法)
  • 多重検出アッセイ

第9章 ラテラルフローアッセイ市場:アプリケーション別

  • イントロダクション
  • 臨床/ポイントオブケア検査
    • 感染症検査
    • 心臓マーカー検査
    • 妊娠・受胎検査
    • コレステロール/脂質検査
    • 薬物乱用検査
    • その他の検査
  • 動物用診断
  • 食品安全・環境試験
  • 創薬・品質試験

第10章 世界のラテラルフローアッセイ市場:エンドユーザー別

  • イントロダクション
  • 病院・クリニック
  • 在宅医療
  • 診断ラボ
  • 医薬品・バイオテクノロジー企業
  • その他

第11章 ラテラルフローアッセイ市場:地域別

  • イントロダクション
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • その他
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ

第12章 競争環境

  • イントロダクション
  • 市場シェア分析
  • 競合状況マッピング
    • ビジョナリーリーダー
    • イノベーター
    • ダイナミック・ディファレンシエーター
    • 新興企業
  • 競合のベンチマーキング
    • 製品ポートフォリオの強み(25社)
    • 事業戦略の長所(25社)

第13章 企業プロファイル

  • ALERE INC.
    • 事業概要
    • 製品ポートフォリオの強み
    • 事業戦略の長所
    • 提供製品
    • 近年の発展動向
    • 事業戦略
  • F. HOFFMANN-LA ROCHE AG
  • DANAHER CORPORATION
  • SIEMENS AG
  • JOHNSON & JOHNSON
  • BECTON, DICKINSON AND COMPANY
  • BIOMERIEUX SA
  • BIO-RAD LABORATORIES, INC.
  • THERMO FISHER SCIENTIFIC, INC.
  • QIAGEN N.V.
  • PERKINELMER INC.
  • ABBOTT LABORATORIES, INC.
  • HOLOGIC, INC.
  • QUIDEL CORPORATION

第14章 付録

図表リスト

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: MD 4158

"The global lateral flow assay market projected to grow at a CAGR of 8.2%."

The global lateral flow assay market is projected to reach USD 8.24 billion by 2022, growing at a CAGR of 8.2% from 2017 to 2022. Factor such as the high prevalence of infectious diseases across the globe, rapidly increasing geriatric population, increasing usage of home-based lateral flow assay devices, and growing demand for point-of-care testing are fueling the growth of the market. However, reluctance towards changing existing diagnostic practices, the implementation of excise duty on medical devices, and stringent & time-consuming regulatory policies are restricting market growth to a certain extent.

"The lateral flow readers segment is expected to register the highest CAGR during the forecast period."

On the basis of product, the lateral flow assay market is segmented into kits & reagents and lateral flow readers. The lateral flow readers segment is expected to register the highest CAGR during the forecast period. The high growth in this segment is attributed to the growing awareness about digital/mobile readers, technological advancements, and higher accuracy offered by these readers.

"Food safety and environmental testing are expected to grow at the highest CAGR during 2017 to 2022."

Based on application, the lateral flow assay market is segmented into clinical/point-of-care testing, veterinary diagnostics, food safety and environmental testing, and drug development & quality control testing. The food safety and environmental testing segment is expected to grow at the highest CAGR during the forecast period. The high growth of this segment is driven by the shifting of the food & beverage industry from lab-based conventional microbiology techniques to rapid lateral flow assay tests.

"APAC is projected to witness the highest growth during the forecast period."

North America held the largest share of the global lateral flow assay market in 2016. On the other hand, the Asia-Pacific region is expected to witness the highest CAGR during the forecast period, owing to the rapidly developing healthcare industry in China and India, growth in aging population, rising life expectancy, rising per capita income, increasing investments in the region by key market players, the expansion of private-sector hospitals & clinics to rural areas, the availability of low-cost labor for manufacturing, presence of a favorable regulatory environment, and growing demand for home and POC testing.

Break of primary participants was as mentioned below:

  • By Company Type - Tier 1-41%, Tier 2-29% and Tier 3-30%
  • By Designation - C-level-34%, Director Level-38%, Others-28%
  • By Region - North America-31%, Europe-33%, Asia-Pacific-19%, Latin America-10%, Middle East & Africa-7%

Some of the major market players in the lateral flow assay market are Alere, Inc. (U.S.), F. Hoffmann-La Roche AG (Switzerland), Danaher Corporation (U.S.), Siemens AG (Germany), Becton, Dickinson and Company (U.S.), bioMerieux SA (France), Johnson & Johnson (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), QIAGEN N.V. (Netherlands), and PerkinElmer, Inc. (U.S.).

Research Coverage:

The report analyzes the various types of kits & reagents and their adoption pattern. It aims at estimating the market size and future growth potential of the global lateral flow assay market for different segments such as product, application, technique, end user, and region. The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report:

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies for strengthening the market.

This report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on product portfolios offered by the top players in the global lateral flow assay market. The report analyzes the global lateral flow assay market by product, application, technique, end user, and region
  • Product Development/Innovation: Detailed insights on upcoming trends and new product launches in the global lateral flow assay market
  • Market Development: Comprehensive information on the lucrative emerging regions by product, application, technique, end user, and region
  • Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the global lateral flow assay market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and products of leading players in the global lateral flow assay market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH APPROACH
    • 2.1.1. SECONDARY SOURCES
      • 2.1.1.1. Key data from secondary sources
    • 2.1.2. PRIMARY SOURCES
      • 2.1.2.1. Key data from primary sources
      • 2.1.2.2. Breakdown of primaries
      • 2.1.2.3. Key industry insights
  • 2.2. MARKET SIZE ESTIMATION
  • 2.3. MARKET BREAKDOWN & DATA TRIANGULATION
  • 2.4. MARKET SHARE ESTIMATION
  • 2.5. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. LATERAL FLOW ASSAYS: MARKET OVERVIEW
  • 4.2. LATERAL FLOW ASSAYS MARKET: DEVELOPED VS. DEVELOPING COUNTRIES
  • 4.3. GEOGRAPHIC SNAPSHOT: LATERAL FLOW ASSAYS MARKET, 2016
  • 4.4. GEOGRAPHIC MIX: LATERAL FLOW ASSAYS MARKET
  • 4.5. ASIA-PACIFIC: LATERAL FLOW ASSAYS MARKET, BY APPLICATION

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. MARKET DRIVERS
      • 5.2.1.1. High prevalence of infectious diseases across the globe
      • 5.2.1.2. Rapidly increasing geriatric population
      • 5.2.1.3. Growing usage of home-based lateral flow assay devices
      • 5.2.1.4. Growing demand for point-of-care testing
    • 5.2.2. MARKET RESTRAINTS
      • 5.2.2.1. Reluctance towards changing existing diagnostic practices
      • 5.2.2.2. Implementation of excise duty on medical devices by the U.S. Government
      • 5.2.2.3. Stringent and time-consuming regulatory policies
    • 5.2.3. MARKET OPPORTUNITIES
      • 5.2.3.1. Growing applications of lateral flow assay tests in clinical diagnostics
      • 5.2.3.2. Increasing applications of lateral flow point-of-need assays
      • 5.2.3.3. Rising demand for lateral flow assays in the food & beverage industry
    • 5.2.4. CHALLENGES
      • 5.2.4.1. Limited reimbursements for lateral flow assay products

6. INDUSTRY INSIGHTS

  • 6.1. INTRODUCTION
  • 6.2. INDUSTRY TRENDS
    • 6.2.1. INTEGRATION OF MICROFLUIDICS TECHNOLOGY IN LATERAL FLOW ASSAYS
    • 6.2.2. DEMAND FOR QUANTITATIVE RESULTS
    • 6.2.3. RISING DEMAND FOR MULTIPLEXED LATERAL FLOW BIOSENSORS
  • 6.3. REGULATORY ANALYSIS
    • 6.3.1. NORTH AMERICA
    • 6.3.2. EUROPE
    • 6.3.3. ASIA
      • 6.3.3.1. India
      • 6.3.3.2. China
      • 6.3.3.3. Japan
  • 6.4. VALUE CHAIN ANALYSIS
  • 6.5. SUPPLY CHAIN ANALYSIS

7. GLOBAL LATERAL FLOW ASSAYS MARKET, BY PRODUCT

  • 7.1. INTRODUCTION
  • 7.2. KITS & REAGENTS
  • 7.3. LATERAL FLOW READERS
    • 7.3.1. DIGITAL/MOBILE READERS
    • 7.3.2. BENCHTOP READERS

8. GLOBAL LATERAL FLOW ASSAYS MARKET, BY TECHNIQUE

  • 8.1. INTRODUCTION
  • 8.2. SANDWICH ASSAYS
  • 8.3. COMPETITIVE ASSAYS
  • 8.4. MULTIPLEX DETECTION ASSAYS

9. GLOBAL LATERAL FLOW ASSAY MARKET, BY APPLICATION

  • 9.1. INTRODUCTION
  • 9.2. CLINICAL/POINT-OF-CARE TESTING
    • 9.2.1. INFECTIOUS DISEASE TESTING
      • 9.2.1.1. Mosquito-borne disease testing
      • 9.2.1.2. Influenza testing
      • 9.2.1.3. Sexually transmitted infections
      • 9.2.1.4. Hepatitis
      • 9.2.1.5. Tuberculosis
      • 9.2.1.6. Other infectious diseases
    • 9.2.2. CARDIAC MARKER TESTING
    • 9.2.3. PREGNANCY & FERTILITY TESTING
      • 9.2.3.1. Pregnancy testing
      • 9.2.3.2. Fertility testing
    • 9.2.4. CHOLESTEROL/LIPID TESTING
    • 9.2.5. DRUGS-OF-ABUSE TESTING
    • 9.2.6. OTHER TESTS
  • 9.3. VETERINARY DIAGNOSTICS
  • 9.4. FOOD SAFETY & ENVIRONMENT TESTING
  • 9.5. DRUG DEVELOPMENT & QUALITY TESTING

10. GLOBAL LATERAL FLOW ASSAYS MARKET, BY END USER

  • 10.1. INTRODUCTION
  • 10.2. HOSPITALS AND CLINICS
  • 10.3. HOME CARE
  • 10.4. DIAGNOSTIC LABORATORIES
  • 10.5. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
  • 10.6. OTHER END USERS

11. LATERAL FLOW ASSAY MARKET, BY REGION

  • 11.1. INTRODUCTION
  • 11.2. NORTH AMERICA
    • 11.2.1. U.S.
    • 11.2.2. CANADA
  • 11.3. EUROPE
    • 11.3.1. GERMANY
    • 11.3.2. FRANCE
    • 11.3.3. U.K.
    • 11.3.4. ITALY
    • 11.3.5. SPAIN
    • 11.3.6. REST OF EUROPE
  • 11.4. ASIA-PACIFIC
    • 11.4.1. JAPAN
    • 11.4.2. CHINA
    • 11.4.3. INDIA
    • 11.4.4. REST OF ASIA-PACIFIC
  • 11.5. LATIN AMERICA
    • 11.5.1. BRAZIL
    • 11.5.2. MEXICO
    • 11.5.3. REST OF LATIN AMERICA
  • 11.6. MIDDLE EAST & AFRICA

12. COMPETITIVE LANDSCAPE

  • 12.1. INTRODUCTION
  • 12.2. MARKET SHARE ANALYSIS
  • 12.3. COMPETITIVE LEADERSHIP MAPPING
    • 12.3.1. VISIONARY LEADERS
    • 12.3.2. INNOVATORS
    • 12.3.3. DYNAMIC DIFFERENTIATORS
    • 12.3.4. EMERGING COMPANIES
  • 12.4. COMPETITIVE BENCHMARKING
    • 12.4.1. STRENGTH OF PRODUCT PORTFOLIO (25 PLAYERS)
    • 12.4.2. BUSINESS STRATEGY EXCELLENCE (25 PLAYERS)

Top 25 companies analysed for this study are - Alere Inc. (U.S.), F. Hoffmann-La Roche AG (Switzerland), Danaher Corporation (U.S.), Siemens AG (Germany), Johnson & Johnson (U.S.), Becton, Dickinson and Company (U.S.), bioMerieux SA (France), Bio-Rad Laboratories, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), QIAGEN N.V. (Netherlands), PerkinElmer, Inc. (U.S.), Abbott Laboratories (U.S.), Hologic, Inc. (U.S.), Merck Millipore (U.S.), Quidel Corporation (U.S.), Abcam plc. (U.S.), DCN Diagnostics (U.S.), Surmodics, Inc. (U.S.), BioPorto Diagnostics A/S (Denmark), Chembio Diagnostic Systems, Inc. (U.S.), Polysciences, Inc. (U.S.), Innova Biosciences Ltd. (U.K.), Microcoat Biotechnologie GmbH (Germany), Senova GmbH (Germany), Scienion AG (Germany)

13. COMPANY PROFILES (Overview, Strength of Product Portfolio Business Strategy Excellence Products Offering, Recent Development's, Business Strategy)*

  • 13.1. ALERE INC.
  • 13.2. F. HOFFMANN-LA ROCHE AG
  • 13.3. DANAHER CORPORATION
  • 13.4. SIEMENS AG
  • 13.5. JOHNSON & JOHNSON
  • 13.6. BECTON, DICKINSON AND COMPANY
  • 13.7. BIOMERIEUX SA
  • 13.8. BIO-RAD LABORATORIES, INC.
  • 13.9. THERMO FISHER SCIENTIFIC INC.
  • 13.10. QIAGEN N.V.
  • 13.11. PERKINELMER INC.
  • 13.12. ABBOTT LABORATORIES
  • 13.13. HOLOGIC, INC.
  • 13.14. QUIDEL CORPORATION

*Details on Overview, Strength of Product Portfolio Business Strategy Excellence Products Offering, Recent Development's, Business Strategy might not be captured in case of unlisted companies.

14. APPENDIX

  • 14.1. INSIGHTS OF INDUSTRY EXPERTS
  • 14.2. DISCUSSION GUIDE
  • 14.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 14.5. AVAILABLE CUSTOMIZATIONS
  • 14.6. RELATED REPORTS
  • 14.7. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: PREVALENCE OF INFECTIOUS DISEASES WORLDWIDE
  • TABLE 2: PREVALENCE OF HIV INFECTION WORLDWIDE (2016)
  • TABLE 3: REGULATORY STANDARD/APPROVAL REQUIRED FOR LATERAL FLOW IMMUNOASSAY PRODUCTS, BY COUNTRY/REGION
  • TABLE 4: GLOBAL LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 5: GLOBAL LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 6: GLOBAL LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 7: LATERAL FLOW READERS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 8: GLOBAL LATERAL FLOW READERS MARKET, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 9: DIGITAL/MOBILE READERS MARKET, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 10: BENCHTOP READERS MARKET, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 11: GLOBAL LATERAL FLOW ASSAYS MARKET, BY TECHNIQUE, 2015-2022 (USD MILLION)
  • TABLE 12: LATERAL FLOW SANDWICH ASSAYS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 13: LATERAL FLOW COMPETITIVE ASSAYS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 14: LATERAL FLOW MULTIPLEX DETECTION ASSAYS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 15: GLOBAL LATERAL FLOW ASSAY MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 16: LATERAL FLOW ASSAY MARKET FOR CLINICAL/POINT-OF-CARE TESTING, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 17: LATERAL FLOW ASSAY MARKET FOR CLINICAL/POINT-OF-CARE TESTING, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 18: INFECTIOUS DISEASE TESTING MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 19: INFECTIOUS DISEASE TESTING MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 20: MOSQUITO-BORNE DISEASE TESTING MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 21: INFLUENZA TESTING MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 22: STI TESTING MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 23: HEPATITIS TESTING MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 24: TUBERCULOSIS TESTING MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 25: OTHER INFECTIOUS DISEASE TESTING MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 26: CARDIAC MARKER TESTING MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 27: PREGNANCY & FERTILITY TESTING MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 28: PREGNANCY & FERTILITY TESTING MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 29: PREGNANCY TESTING MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 30: FERTILITY TESTING MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 31: CHOLESTEROL/LIPID TESTING MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 32: DRUGS-OF-ABUSE TESTING MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 33: OTHER CLINICAL/POINT-OF-CARE TESTS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 34: LATERAL FLOW ASSAY MARKET FOR VETERINARY DIAGNOSTICS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 35: LATERAL FLOW ASSAY MARKET FOR FOOD SAFETY & ENVIRONMENTAL TESTING, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 36: LATERAL FLOW ASSAY MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 37: GLOBAL LATERAL FLOW ASSAYS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 38: LATERAL FLOW ASSAYS MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 39: LATERAL FLOW ASSAYS MARKET FOR HOME CARE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 40: LATERAL FLOW ASSAYS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 41: LATERAL FLOW ASSAYS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 42: LATERAL FLOW ASSAYS MARKET FOR OTHER END USERS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 43: NORTH AMERICA: LATERAL FLOW ASSAY MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 44: NORTH AMERICA: LATERAL FLOW ASSAY MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 45: NORTH AMERICA: LATERAL FLOW READERS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 46: NORTH AMERICA: LATERAL FLOW ASSAY MARKET, BY TECHNIQUE, 2015-2022 (USD MILLION)
  • TABLE 47: NORTH AMERICA: LATERAL FLOW ASSAY MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 48: NORTH AMERICA: CLINICAL/POINT-OF-CARE TESTING, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 49: NORTH AMERICA: INFECTIOUS DISEASE TESTING MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 50: NORTH AMERICA: PREGNANCY AND FERTILITY TESTING MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 51: NORTH AMERICA: LATERAL FLOW ASSAY MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 52: U.S.: MACROECONOMIC INDICATORS
  • TABLE 53: U.S.: LATERAL FLOW ASSAY MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 54: U.S.: LATERAL FLOW READERS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 55: U.S.: LATERAL FLOW ASSAY MARKET, BY TECHNIQUE, 2015-2022 (USD MILLION)
  • TABLE 56: U.S.: LATERAL FLOW ASSAY MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 57: U.S.: CLINICAL/POINT-OF-CARE TESTING, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 58: U.S.: INFECTIOUS DISEASE TESTING MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 59: U.S.: PREGNANCY AND FERTILITY TESTING MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 60: U.S.: LATERAL FLOW ASSAY MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 61: CANADA: MACROECONOMIC INDICATORS
  • TABLE 62: CANADA: LATERAL FLOW ASSAY MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 63: CANADA: LATERAL FLOW READERS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 64: CANADA: LATERAL FLOW ASSAY MARKET, BY TECHNIQUE, 2015-2022 (USD MILLION)
  • TABLE 65: CANADA: LATERAL FLOW ASSAY MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 66: CANADA: CLINICAL/POINT-OF-CARE TESTING, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 67: CANADA: INFECTIOUS DISEASE TESTING MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 68: CANADA: PREGNANCY AND FERTILITY TESTING MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 69: CANADA: LATERAL FLOW ASSAY MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 70: EUROPE: LATERAL FLOW ASSAY MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 71: EUROPE: LATERAL FLOW ASSAY MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 72: EUROPE: LATERAL FLOW READERS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 73: EUROPE: LATERAL FLOW ASSAY MARKET, BY TECHNIQUE, 2015-2022 (USD MILLION)
  • TABLE 74: EUROPE: LATERAL FLOW ASSAY MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 75: EUROPE: CLINICAL/POINT-OF-CARE TESTING, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 76: EUROPE: INFECTIOUS DISEASE TESTING MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 77: EUROPE: PREGNANCY AND FERTILITY TESTING MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 78: EUROPE: LATERAL FLOW ASSAY MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 79: GERMANY: MACROECONOMIC INDICATORS
  • TABLE 80: GERMANY: LATERAL FLOW ASSAY MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 81: GERMANY: LATERAL FLOW READERS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 82: GERMANY: LATERAL FLOW ASSAY MARKET, BY TECHNIQUE, 2015-2022 (USD MILLION)
  • TABLE 83: GERMANY: LATERAL FLOW ASSAY MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 84: GERMANY: CLINICAL/POINT-OF-CARE TESTING, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 85: GERMANY: INFECTIOUS DISEASE TESTING MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 86: GERMANY: PREGNANCY AND FERTILITY TESTING MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 87: GERMANY: LATERAL FLOW ASSAY MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 88: FRANCE: MACROECONOMIC INDICATORS
  • TABLE 89: FRANCE: LATERAL FLOW ASSAY MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 90: FRANCE: LATERAL FLOW READERS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 91: FRANCE: LATERAL FLOW ASSAY MARKET, BY TECHNIQUE, 2015-2022 (USD MILLION)
  • TABLE 92: FRANCE: LATERAL FLOW ASSAY MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 93: FRANCE: CLINICAL/POINT-OF-CARE TESTING, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 94: FRANCE: INFECTIOUS DISEASE TESTING MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 95: FRANCE: PREGNANCY AND FERTILITY TESTING MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 96: FRANCE: LATERAL FLOW ASSAY MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 97: U.K.: MACROECONOMIC INDICATORS
  • TABLE 98: U.K.: LATERAL FLOW ASSAY MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 99: U.K.: LATERAL FLOW READERS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 100: U.K.: LATERAL FLOW ASSAY MARKET, BY TECHNIQUE, 2015-2022 (USD MILLION)
  • TABLE 101: U.K.: LATERAL FLOW ASSAY MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 102: U.K.: CLINICAL/POINT-OF-CARE TESTING, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 103: U.K.: INFECTIOUS DISEASE TESTING MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 104: U.K.: PREGNANCY AND FERTILITY TESTING MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 105: U.K.: LATERAL FLOW ASSAY MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 106: ITALY: MACROECONOMIC INDICATORS
  • TABLE 107: ITALY: LATERAL FLOW ASSAY MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 108: ITALY: LATERAL FLOW READERS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 109: ITALY: LATERAL FLOW ASSAY MARKET, BY TECHNIQUE, 2015-2022 (USD MILLION)
  • TABLE 110: ITALY: LATERAL FLOW ASSAY MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 111: ITALY: CLINICAL/POINT-OF-CARE TESTING, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 112: ITALY: INFECTIOUS DISEASE TESTING MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 113: ITALY: PREGNANCY AND FERTILITY TESTING MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 114: ITALY: LATERAL FLOW ASSAY MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 115: SPAIN: MACROECONOMIC INDICATORS
  • TABLE 116: SPAIN: LATERAL FLOW ASSAY MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 117: SPAIN: LATERAL FLOW READERS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 118: SPAIN: LATERAL FLOW ASSAY MARKET, BY TECHNIQUE, 2015-2022 (USD MILLION)
  • TABLE 119: SPAIN: LATERAL FLOW ASSAY MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 120: SPAIN: CLINICAL/POINT-OF-CARE TESTING, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 121: SPAIN: INFECTIOUS DISEASE TESTING MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 122: SPAIN: PREGNANCY AND FERTILITY TESTING MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 123: SPAIN: LATERAL FLOW ASSAY MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 124: ROE: LATERAL FLOW ASSAY MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 125: ROE: LATERAL FLOW READERS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 126: ROE: LATERAL FLOW ASSAY MARKET, BY TECHNIQUE, 2015-2022 (USD MILLION)
  • TABLE 127: ROE: LATERAL FLOW ASSAY MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 128: ROE: CLINICAL/POINT-OF-CARE TESTING, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 129: ROE: INFECTIOUS DISEASE TESTING MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 130: ROE: PREGNANCY AND FERTILITY TESTING MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 131: ROE: LATERAL FLOW ASSAY MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 132: APAC: LATERAL FLOW ASSAY MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 133: APAC: LATERAL FLOW ASSAY MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 134: APAC: LATERAL FLOW READERS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 135: APAC: LATERAL FLOW ASSAY MARKET, BY TECHNIQUE, 2015-2022 (USD MILLION)
  • TABLE 136: APAC: LATERAL FLOW ASSAY MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 137: APAC: CLINICAL/POINT-OF-CARE TESTING, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 138: APAC: INFECTIOUS DISEASE TESTING MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 139: APAC: PREGNANCY AND FERTILITY TESTING MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 140: APAC: LATERAL FLOW ASSAY MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 141: JAPAN: MACROECONOMIC INDICATORS
  • TABLE 142: JAPAN: LATERAL FLOW ASSAY MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 143: JAPAN: LATERAL FLOW READERS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 144: JAPAN: LATERAL FLOW ASSAY MARKET, BY TECHNIQUE, 2015-2022 (USD MILLION)
  • TABLE 145: JAPAN: LATERAL FLOW ASSAY MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 146: JAPAN: CLINICAL/POINT-OF-CARE TESTING, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 147: JAPAN: INFECTIOUS DISEASE TESTING MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 148: JAPAN: PREGNANCY AND FERTILITY TESTING MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 149: JAPAN: LATERAL FLOW ASSAY MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 150: CHINA: MACROECONOMIC INDICATORS
  • TABLE 151: CHINA: LATERAL FLOW ASSAY MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 152: CHINA: LATERAL FLOW READERS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 153: CHINA: LATERAL FLOW ASSAY MARKET, BY TECHNIQUE, 2015-2022 (USD MILLION)
  • TABLE 154: CHINA: LATERAL FLOW ASSAY MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 155: CHINA: CLINICAL/POINT-OF-CARE TESTING, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 156: CHINA: INFECTIOUS DISEASE TESTING MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 157: CHINA: PREGNANCY AND FERTILITY TESTING MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 158: CHINA: LATERAL FLOW ASSAY MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 159: INDIA: MACROECONOMIC INDICATORS
  • TABLE 160: INDIA: LATERAL FLOW ASSAY MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 161: INDIA: LATERAL FLOW READERS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 162: INDIA: LATERAL FLOW ASSAY MARKET, BY TECHNIQUE, 2015-2022 (USD MILLION)
  • TABLE 163: INDIA: LATERAL FLOW ASSAY MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 164: INDIA: CLINICAL/POINT-OF-CARE TESTING, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 165: INDIA: INFECTIOUS DISEASE TESTING MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 166: INDIA: PREGNANCY AND FERTILITY TESTING MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 167: INDIA: LATERAL FLOW ASSAY MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 168: ROAPAC: LATERAL FLOW ASSAY MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 169: ROAPAC: LATERAL FLOW READERS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 170: ROAPAC: LATERAL FLOW ASSAY MARKET, BY TECHNIQUE, 2015-2022 (USD MILLION)
  • TABLE 171: ROAPAC: LATERAL FLOW ASSAY MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 172: ROAPAC: CLINICAL/POINT-OF-CARE TESTING, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 173: ROAPAC: INFECTIOUS DISEASE TESTING MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 174: ROAPAC: PREGNANCY AND FERTILITY TESTING MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 175: ROAPAC: LATERAL FLOW ASSAY MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 176: LATIN AMERICA: LATERAL FLOW ASSAY MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 177: LATIN AMERICA: LATERAL FLOW ASSAY MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 178: LATIN AMERICA: LATERAL FLOW READERS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 179: LATIN AMERICA: LATERAL FLOW ASSAY MARKET, BY TECHNIQUE, 2015-2022 (USD MILLION)
  • TABLE 180: LATIN AMERICA: LATERAL FLOW ASSAY MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 181: LATIN AMERICA: CLINICAL/POINT-OF-CARE TESTING, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 182: LATIN AMERICA: INFECTIOUS DISEASE TESTING MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 183: LATIN AMERICA: PREGNANCY AND FERTILITY TESTING MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 184: LATIN AMERICA: LATERAL FLOW ASSAY MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 185: BRAZIL: MACROECONOMIC INDICATORS
  • TABLE 186: BRAZIL: LATERAL FLOW ASSAY MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 187: BRAZIL: LATERAL FLOW READERS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 188: BRAZIL: LATERAL FLOW ASSAY MARKET, BY TECHNIQUE, 2015-2022 (USD MILLION)
  • TABLE 189: BRAZIL: LATERAL FLOW ASSAY MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 190: BRAZIL: CLINICAL/POINT-OF-CARE TESTING, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 191: BRAZIL: INFECTIOUS DISEASE TESTING MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 192: BRAZIL: PREGNANCY AND FERTILITY TESTING MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 193: BRAZIL: LATERAL FLOW ASSAY MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 194: MEXICO: MACROECONOMIC INDICATORS
  • TABLE 195: MEXICO: LATERAL FLOW ASSAY MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 196: MEXICO: LATERAL FLOW READERS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 197: MEXICO: LATERAL FLOW ASSAY MARKET, BY TECHNIQUE, 2015-2022 (USD MILLION)
  • TABLE 198: MEXICO: LATERAL FLOW ASSAY MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 199: MEXICO: CLINICAL/POINT-OF-CARE TESTING, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 200: MEXICO: INFECTIOUS DISEASE TESTING MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 201: MEXICO: PREGNANCY AND FERTILITY TESTING MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 202: MEXICO: LATERAL FLOW ASSAY MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 203: ROLATAM: LATERAL FLOW ASSAY MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 204: ROLATAM: LATERAL FLOW READERS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 205: ROLATAM: LATERAL FLOW ASSAY MARKET, BY TECHNIQUE, 2015-2022 (USD MILLION)
  • TABLE 206: ROLATAM: LATERAL FLOW ASSAY MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 207: ROLATAM: CLINICAL/POINT-OF-CARE TESTING, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 208: ROLATAM: INFECTIOUS DISEASE TESTING MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 209: ROLATAM: PREGNANCY AND FERTILITY TESTING MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 210: ROLATAM: LATERAL FLOW ASSAY MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 211: MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 212: MIDDLE EAST & AFRICA: LATERAL FLOW READERS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 213: MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY MARKET, BY TECHNIQUE, 2015-2022 (USD MILLION)
  • TABLE 214: MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 215: MIDDLE EAST & AFRICA: CLINICAL/POINT-OF-CARE TESTING, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 216: MIDDLE EAST & AFRICA: INFECTIOUS DISEASE TESTING MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 217: MIDDLE EAST & AFRICA: PREGNANCY AND FERTILITY TESTING MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 218: MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY MARKET, BY END USER, 2015-2022 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATIONS, AND REGION
  • FIGURE 3: BOTTOM-UP APPROACH
  • FIGURE 4: TOP-DOWN APPROACH
  • FIGURE 5: DATA TRIANGULATION METHODOLOGY
  • FIGURE 6: GLOBAL LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2017 VS. 2022 (USD MILLION)
  • FIGURE 7: GLOBAL LATERAL FLOW ASSAYS MARKET, BY TECHNIQUE, 2017 VS. 2022 (USD MILLION)
  • FIGURE 8: GLOBAL LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2017 VS. 2022 (USD MILLION)
  • FIGURE 9: GLOBAL LATERAL FLOW ASSAYS MARKET, BY END USER, 2017 VS. 2022 (USD MILLION)
  • FIGURE 10: GEOGRAPHICAL SNAPSHOT OF THE GLOBAL LATERAL FLOW ASSAYS MARKET
  • FIGURE 11: RAPID GROWTH IN THE GERIATRIC POPULATION-KEY FACTOR DRIVING MARKET GROWTH FOR LATERAL FLOW ASSAYS
  • FIGURE 12: DEVELOPING MARKETS TO REGISTER HIGHER GROWTH DURING THE FORECAST PERIOD
  • FIGURE 13: U.S. ACCOUNTED FOR THE LARGEST SHARE OF THE LATERAL FLOW ASSAYS MARKET IN 2016
  • FIGURE 14: NORTH AMERICA WILL CONTINUE TO DOMINATE THE LATERAL FLOW ASSAYS MARKET IN 2022
  • FIGURE 15: CLINICAL TESTING SEGMENT COMMANDED THE LARGEST SHARE OF THE ASIA PACIFIC LATERAL FLOW ASSAY MARKET IN 2016
  • FIGURE 16: LATERAL FLOW ASSAYS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES
  • FIGURE 17: GLOBAL ELDERLY POPULATION, BY REGION, 2010 VS. 2015 VS. 2030
  • FIGURE 18: GLOBAL ELDERLY POPULATION, BY COUNTRY, 2005 VS. 2015
  • FIGURE 19: LATERAL FLOW ASSAYS MARKET: VALUE CHAIN ANALYSIS (2016)
  • FIGURE 20: LATERAL FLOW ASSAYS MARKET: SUPPLY CHAIN ANALYSIS (2016)
  • FIGURE 21: KITS & REAGENTS SEGMENT WILL CONTINUE TO DOMINATE THE GLOBAL LATERAL FLOW ASSAYS MARKET BY 2022
  • FIGURE 22: THE SANDWICH ASSAYS MARKET TO DOMINATE THE GLOBAL LATERAL FLOW ASSAYS MARKET IN THE FORECAST PERIOD
  • FIGURE 23: CLINICAL TESTING SEGMENT TO DOMINATED THE GLOBAL LATERAL FLOW ASSAY MARKET, BY APPLICATION, DURING THE FORECAST PERIOD
  • FIGURE 24: PATIENTS BEING TREATED FOR HIV GLOBALLY, 2000-2015
  • FIGURE 25: HOSPITALS AND CLINICS DOMINATED THE GLOBAL LATERAL FLOW ASSAYS MARKET DURING FORECAST PERIOD
  • FIGURE 26: GEOGRAPHICAL SNAPSHOT
  • FIGURE 27: NORTH AMERICA: LATERAL FLOW ASSAY MARKET SNAPSHOT
  • FIGURE 28: EUROPE: LATERAL FLOW ASSAY MARKET SNAPSHOT
  • FIGURE 29: GLOBAL LATERAL FLOW ASSAYS MARKET SHARE ANALYSIS, BY KEY PLAYER (2016)
  • FIGURE 30: LATERAL FLOW ASSAYS MARKET (GLOBAL) COMPETITIVE LEADERSHIP MAPPING, 2017
  • FIGURE 31: ALERE, INC.: COMPANY SNAPSHOT (2016)
  • FIGURE 32: F. HOFFMANN-LA ROCHE AG: COMPANY SNAPSHOT (2016)
  • FIGURE 33: DANAHER CORPORATION: COMPANY SNAPSHOT (2016)
  • FIGURE 34: SIEMENS AG: COMPANY SNAPSHOT (2016)
  • FIGURE 35: JOHNSON & JOHNSON: COMPANY SNAPSHOT (2016)
  • FIGURE 36: BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2016)
  • FIGURE 37: BIOMERIEUX SA: COMPANY SNAPSHOT (2016)
  • FIGURE 38: BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2016)
  • FIGURE 39: THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2016)
  • FIGURE 40: QIAGEN N.V.: COMPANY SNAPSHOT (2016)
  • FIGURE 41: PERKINELMER, INC.: COMPANY SNAPSHOT (2016)
  • FIGURE 42: ABBOTT LABORATORIES: COMPANY SNAPSHOT (2016)
  • FIGURE 43: HOLOGIC, INC.: COMPANY SNAPSHOT (2016)
  • FIGURE 44: QUIDEL CORPORATION: COMPANY SNAPSHOT (2016)
Back to Top